Viewing data from:

TRI-LEGEST FE

ANDA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | A076105 | BARR LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.8221

per ea

Lowest NADAC/Unit

$0.8221

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00555903270TRI-LEGEST FE-28 DAY TABLET	$0.8221	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

Medicare Part D Spending

CMS annual spending data for Tri-Legest Fe (2024)

Total Spending

$23K

Total Claims

406

Beneficiaries

Avg Cost/Unit

$1.24

Spending Trend

$58K(2019)→$56K(2020)→$55K(2021)→$37K(2022)→$27K(2023)→$23K(2024)

YoY Change:-6.5%

5yr CAGR:-4.4%

Source: CMS Medicare Part D Spending by Drug (2024). Shows gross drug cost under Part D.

Products (1)

#001 — 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Oct 26, 2007

No patent or exclusivity listings for this strength.